Follow this preprint
Poor antigen-specific responses to the second BNT162b2 mRNA vaccine dose in SARS-CoV-2-experienced individuals
Marie I. Samanovic, Amber R. Cornelius, Jimmy P. Wilson, Trishala Karmacharya, View ORCID ProfileSophie L. Gray-Gaillard, Joseph Richard Allen, Sara Wesley Hyman, Gali Moritz, Mahnoor Ali, View ORCID ProfileSergei B. Koralov, View ORCID ProfileMark J. Mulligan, View ORCID ProfileRamin Sedaghat Herati
doi: https://doi.org/10.1101/2021.02.07.21251311
Now published in Science Translational Medicine doi: 10.1126/scitranslmed.abi8961
Marie I. Samanovic
1NYU Langone Vaccine Center, Department of Medicine, New York University School of Medicine, New York, NY
Amber R. Cornelius
1NYU Langone Vaccine Center, Department of Medicine, New York University School of Medicine, New York, NY
Jimmy P. Wilson
1NYU Langone Vaccine Center, Department of Medicine, New York University School of Medicine, New York, NY
Trishala Karmacharya
1NYU Langone Vaccine Center, Department of Medicine, New York University School of Medicine, New York, NY
Sophie L. Gray-Gaillard
1NYU Langone Vaccine Center, Department of Medicine, New York University School of Medicine, New York, NY
Joseph Richard Allen
1NYU Langone Vaccine Center, Department of Medicine, New York University School of Medicine, New York, NY
Sara Wesley Hyman
1NYU Langone Vaccine Center, Department of Medicine, New York University School of Medicine, New York, NY
Gali Moritz
1NYU Langone Vaccine Center, Department of Medicine, New York University School of Medicine, New York, NY
Mahnoor Ali
1NYU Langone Vaccine Center, Department of Medicine, New York University School of Medicine, New York, NY
Sergei B. Koralov
2Department of Pathology, New York University School of Medicine, New York, NY
Mark J. Mulligan
1NYU Langone Vaccine Center, Department of Medicine, New York University School of Medicine, New York, NY
Ramin Sedaghat Herati
1NYU Langone Vaccine Center, Department of Medicine, New York University School of Medicine, New York, NY

Article usage
Picked up by 69 news outlets
Blogged by 2
Tweeted by 705
On 1 Facebook pages
98 readers on Mendeley
Posted February 09, 2021.
Poor antigen-specific responses to the second BNT162b2 mRNA vaccine dose in SARS-CoV-2-experienced individuals
Marie I. Samanovic, Amber R. Cornelius, Jimmy P. Wilson, Trishala Karmacharya, Sophie L. Gray-Gaillard, Joseph Richard Allen, Sara Wesley Hyman, Gali Moritz, Mahnoor Ali, Sergei B. Koralov, Mark J. Mulligan, Ramin Sedaghat Herati
medRxiv 2021.02.07.21251311; doi: https://doi.org/10.1101/2021.02.07.21251311
Now published in Science Translational Medicine doi: 10.1126/scitranslmed.abi8961
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
71
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (410)
- Allergy and Immunology (722)
- Anesthesia (214)
- Cardiovascular Medicine (3070)
- Dermatology (259)
- Emergency Medicine (461)
- Epidemiology (13000)
- Forensic Medicine (13)
- Gastroenterology (858)
- Genetic and Genomic Medicine (4808)
- Geriatric Medicine (443)
- Health Economics (749)
- Health Informatics (3044)
- Health Policy (1100)
- Hematology (406)
- HIV/AIDS (954)
- Medical Education (453)
- Medical Ethics (119)
- Nephrology (497)
- Neurology (4585)
- Nursing (243)
- Nutrition (680)
- Oncology (2378)
- Ophthalmology (671)
- Orthopedics (267)
- Otolaryngology (332)
- Pain Medicine (300)
- Palliative Medicine (87)
- Pathology (514)
- Pediatrics (1235)
- Primary Care Research (517)
- Public and Global Health (7163)
- Radiology and Imaging (1595)
- Respiratory Medicine (942)
- Rheumatology (458)
- Sports Medicine (400)
- Surgery (507)
- Toxicology (65)
- Transplantation (219)
- Urology (188)